Cebiotex Overview

  • Founded
  • 2012

Founded
  • Status
  • Private

  • Employees
  • 7

Employees
  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $4.72M

  • Investors
  • 6

Cebiotex General Information

Description

Developer of electrospun nanofiber technology designed to help in local treatment of unresectable cancer tumors. The company's electrospun nanofiber technology has developed in vitro and in vivo and preclinical nonwoven nanofiber membranes for the controlled release of active agents, enabling medical professionals to treat unresectable cancer tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Drug Discovery
Primary Office
  • Pau Vila Square, Number 1
  • Block A, 3rd Floor, Barcelona Tech City
  • 08039 Barcelona
  • Spain

Cebiotex Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cebiotex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series A) 24-Sep-2021 $4.72M 000.00 000.00 Completed Generating Revenue
10. Equity Crowdfunding 22-Dec-2020 00000 00.000 000.00 Completed Generating Revenue
9. Later Stage VC 23-Dec-2019 00.00 00.000 00.000 Completed Generating Revenue
8. Seed Round 16-Feb-2017 00.000 00.000 Completed Generating Revenue
7. Early Stage VC 15-Dec-2016 00.000 00.000 00.000 Completed Generating Revenue
6. Grant 12-Dec-2016 000.00 00.000 Completed Generating Revenue
5. Equity Crowdfunding 31-May-2016 00000 00.000 00.000 Completed Startup
4. Equity Crowdfunding 00000 00.000 Completed Startup
3. Seed Round 27-Feb-2015 $567K $2.4M 00.000 Completed Startup
2. Seed Round 19-Nov-2013 $1.83M $1.83M Completed Startup
To view Cebiotex’s complete valuation and funding history, request access »

Cebiotex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 0,000 00.000000 0000 0000 00 0000 00.000
To view Cebiotex’s complete cap table history, request access »

Cebiotex Executive Team (7)

Name Title Board Seat Contact Info
Joan Llavina Co-Founder, President, Chairman & Chief Executive Officer
Luc Marti Ph.D Chief Operating Officer
Jose Tornero Co-Founder, Chief Technology Officer & Board Member
Imma Turro Chief Business Officer
Lucas Krauel Ph.D Co-Founder, Chief Surgical Officer & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

Cebiotex Board Members (8)

Name Representing Role Since
Antonio Villaró Self Board Member 000 0000
Carolina La Valle Self Board Member 000 0000
Emili Bargalló Self Board Member 000 0000
Jose Tornero Cebiotex Co-Founder, Chief Technology Officer & Board Member 000 0000
Lucas Krauel Ph.D Cebiotex Co-Founder, Chief Surgical Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Cebiotex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cebiotex Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Inveready Technology Investment Group Venture Capital Minority 000 0000 000000 0
Ship2B Accelerator/Incubator Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Barcelona Activa Accelerator/Incubator Minority 000 0000 000000 0
Biocat Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »